Impact of granting a Conditional Marketing Authorisation for Pfizer-BioNTech COVID-19 vaccine (Comirnaty®)

Document first published:
Page updated:
Topic:
,
Publication type:

This letter draws attention to a number of operational implications for the management of the Pfizer-BioNTech vaccines and asks for appropriate steps to be taken to make relevant colleagues aware.

Summary

Letter from Dr Keith Ridge CBE, Chief Pharmaceutical Officer for England.